Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
PayPal
PYPL
|
+$650M |
| 2 |
Home Depot
HD
|
+$617M |
| 3 |
Costco
COST
|
+$570M |
| 4 |
Caterpillar
CAT
|
+$524M |
| 5 |
AbbVie
ABBV
|
+$506M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Booking.com
BKNG
|
+$555M |
| 3 |
CELG
Celgene Corp
CELG
|
+$537M |
| 4 |
Crown Castle
CCI
|
+$509M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$423M |
Sector Composition
| 1 | Technology | 20.86% |
| 2 | Consumer Discretionary | 15.65% |
| 3 | Financials | 12.8% |
| 4 | Healthcare | 12.57% |
| 5 | Communication Services | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Norfolk Southern
NSC
$61.1B
| $4.21M | ﹤0.01% |
+29,044
| New | +$4.21M |
|
|
BWP
502
DELISTED
Boardwalk Pipeline Partners
BWP
| $4.09M | ﹤0.01% |
316,517
-40
| -0% | -$516 |
|
|
SBT
503
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $3.62M | ﹤0.01% |
+284,969
| New | +$3.62M |
|
504
Rocket Pharmaceuticals
RCKT
$343M
| $3.57M | ﹤0.01% |
341,713
-47,466
| -12% | -$495K |
|
|
MON
505
DELISTED
Monsanto Co
MON
| $3.47M | ﹤0.01% |
29,681
+16,053
| +118% | +$1.87M |
|
506
IBM
IBM
$239B
| $3.45M | ﹤0.01% |
23,521
-774
| -3% | -$114K |
|
|
CNR
507
Core Natural Resources, Inc.
CNR
$3.74B
| $3.3M | ﹤0.01% |
+83,621
| New | +$3.3M |
|
508
First Bancorp
FBNC
$2.27B
| $3.28M | ﹤0.01% |
92,940
+2,152
| +2% | +$76K |
|
|
NAK
509
Northern Dynasty Minerals
NAK
$450M
| $3.12M | ﹤0.01% |
1,763,422
| – | – |
|
510
Tempest Therapeutics
TPST
$46.7M
| $3.06M | ﹤0.01% |
748
| – | – |
|
511
LyondellBasell Industries
LYB
$17.5B
| $2.89M | ﹤0.01% |
26,233
+13,851
| +112% | +$1.53M |
|
512
Johnson & Johnson
JNJ
$423B
| $2.8M | ﹤0.01% |
20,053
-1,603
| -7% | -$224K |
|
513
iShares MSCI India ETF
INDA
$9.38B
| $2.73M | ﹤0.01% |
75,552
| – | – |
|
514
Northrop Grumman
NOC
$83B
| $2.67M | ﹤0.01% |
8,691
-481
| -5% | -$148K |
|
|
RNTX
515
Rein Therapeutics, Inc. Common Stock
RNTX
$27.7M
| $2.66M | ﹤0.01% |
12,612
+145
| +1% | +$30.6K |
|
516
REV Group
REVG
$3.06B
| $2.41M | ﹤0.01% |
+73,923
| New | +$2.41M |
|
517
Micron Technology
MU
$157B
| $2.36M | ﹤0.01% |
57,301
-8,434
| -13% | -$347K |
|
518
Sociedad Química y Minera de Chile
SQM
$12B
| $2.32M | ﹤0.01% |
38,990
+1,197
| +3% | +$71.1K |
|
519
Seres Therapeutics
MCRB
$154M
| $2.31M | ﹤0.01% |
+11,379
| New | +$2.31M |
|
520
NXP Semiconductors
NXPI
$55.3B
| $2.2M | ﹤0.01% |
+18,801
| New | +$2.2M |
|
521
MakeMyTrip
MMYT
$9.1B
| $2.2M | ﹤0.01% |
73,562
+1,606
| +2% | +$47.9K |
|
522
Tri Pointe Homes
TPH
$3.07B
| $2.14M | ﹤0.01% |
119,392
+37,455
| +46% | +$671K |
|
|
RTN
523
DELISTED
Raytheon Company
RTN
| $2.1M | ﹤0.01% |
11,154
-269
| -2% | -$50.5K |
|
524
Agilent Technologies
A
$35.2B
| $2.09M | ﹤0.01% |
31,158
-1,676
| -5% | -$112K |
|
525
Protagonist Therapeutics
PTGX
$3.59B
| $2.08M | ﹤0.01% |
+100,000
| New | +$2.08M |
|